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Abstract
Background: Shigellosis is an acute invasive enteric infection caused by bacteria belonging to the genus Shigella;
it is clinically manifested by bloody diarrhoea. Shigellosis is endemic in many developing countries including
Cameroon and also occurs in epidemics causing considerable morbidity and mortality. This study evaluated the
epidemiological and clinical features of Shigella and the resistance pattern of isolates to commonly used antibiotics
in the Buea Health District in Cameroon, from April to August, 2010.
Results: Of the 223 stool samples cultured, 10 (4.5%) yielded Shigella species. Isolation rate was observed to be
more in children below 15 years (7.89%), and also higher in rural areas (6.35%). All 10 isolates showed resistance to
at least two antibiotics and 9 (90%) were multi-drug resistant. The highest resistance rates were encountered with
cotrimoxazole (90%) and amoxicillin (80%). Least resistance was observed with azithromycin (10%).
Conclusion: Shigellosis is more prevalent in children below 15 years in the Buea District. There is a high level of
resistance to most of the antibiotics used for the treatment of shigellosis including extended-spectrum beta-
lactamases (ESBLs) as well as evidence of resistance to quinolones. Azithromycin was found to be the drug of
choice for shigellosis in this setting.
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Background
Shigellosis (bacillary dysentery) is a global health pro-
blem, especially in developing countries, where substan-
dard hygienic conditions and unsafe water supplies
prevail [1]. Among the bacterial causes of dysentery,
Shigella species continue to be the most important, with
a high infectivity rate and the development of antimicro-
bial resistance. Shigellosis is said to be a self-limiting
disease, although antimicrobial therapy is recommended
[2]. Since 1940, when resistance of Shigella species to
sulfonamide was first recognized in Japan [3], resistance
of Shigella species have become progressively recorded
to most widely-used antimicrobial agents [4]. Multiple-
drug resistance transmitted plasmids among Shigella
species have been reported in many countries [5]. So
far, limited reports exist on the occurrence and antibio-
tic resistance patterns of Shigella species in Buea in par-
ticular and in Cameroon in general. The purpose of the
present study was to determine the epidemiologic pro-
files of Shigella and their antimicrobial resistance pat-
terns in the Buea Health District, in the South West
Region of Cameroon.
Results and discussion
Of the 223 stool specimens cultured for Shigella species,
10 were tested positive with a prevalence of 4.5%. Find-
ings from other authors [6-8] indicate slightly higher
prevalence rates of 8.0%, 7.4% and 7.3% respectively,
than what is obtained in this study.
The majority of Shigella isolates were from the paedia-
tric population (children < 15 years) with an infection
rate of 7.89% while no infection was recorded with
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any medium, provided the original work is properly cited.individuals aged > 45 years. In line with our findings, a
higher prevalence of infection in children was observed
in a previous work [9], in which 70% of all infections
occurred in children below 15 years. It was also noted
that children of this age group accounted for more than
at h i r do fa l lShigella positive patients [8]. Scientific
findings have revealed that type-specific immunity devel-
ops after repeated exposures during childhood [10].
Diarrhoea account for about 16% of all causes of mortal-
ity in children [11], because they are at an immature
age, and they are in frequent exposure to contaminated
environment due to play-related activities and are not
being drilled on the importance of hand-washing after
defecation and before eating.
Considering the source of water of these participants,
it was noted that most participants 181 (81.17%) used
pipe-borne water, while 38(17.04%) used springs and 4
(1.79%) fetched from the river. Of the 10 isolates, 7
(70%) occurred in patients whose drinking water was
obtained from springs and 3 (30%) of patients who con-
sume pipe-borne water with no significance (p > 0.05).
Abdominal pain, fever and diarrhoea were the most
common clinical symptoms. Out of the 60 (26.91%)
patients that presented with diarrhoea and 9 (4.0%) with
dysentery, 2(3.33%) and 2 (22.22%) respectively, yielded
Shigella species. There was a significant difference
between dysentery and infection (p < 0.05) while it was
not the case with the other clinical conditions (p >
0.05). Of the ten positive isolates, 3(30%) were from
formed and semi formed stool samples each while 2
(20%) were from mucous and bloody mucous stool,
each. Analyses of disease occurrence for shigellosis have
faced difficulties, diagnosis especially at the clinical
levels, are often missed because many cases are asymp-
tomatic or present with atypical features such as watery
diarrhoea and fever. Bloody diarrhoea has been the
major clinical presentation associated to shigellosis [12];
nonetheless there exists other presentations which range
from asymptomatic carriage, to mild watery diarrhoea,
to overt dysentery characterized by frequent, but small
volume, loose stools, consisting largely of blood and
mucus [13]. It was observed in this study that although
bloody diarrhoeas accounted for 22.22% of the infec-
tions; watery (11.76%), formed (2.4%) as well as semi-
formed (5.56%) stools also yielded Shigella. Isolation of
Shigella from formed and semi-formed stools is an indi-
cation that the patients were in the period of convales-
cence though still harboring the germ. Responses to
questions administered to medical doctors revealed that,
in the treatment of bloody diarrhoeas, stool cultures and
antibiotic susceptibility testing were hardly ever
requested due to lack of appropriate facilities in these
treatment centers thus favoring the tendency of pre-
scribing antibiotics on the basis of clinical diagnosis
alone. Implying that diagnosis on the bases of clinical
symptoms alone could be misleading. The misuse of
antibiotics is considered the most important factor pro-
moting the emergence, selection and dissemination of
antimicrobial resistance observed with many bacteria
[14,15]. This study also determined the sensitivity and
resistance patterns of the isolates to various antibiotics
commonly used for the treatment of shigellosis. From
the results of the antibiogram, azithromycin (macrolide)
was the most sensitive drug, with a sensitivity rate of
80% seconded by ofloxacin and ceftriaxone both of
them recording sensitivity rates70% (Table 1). Though
the sensitivity of azithromycin has not yet been recorded
in previous studies, it was proved to be potent in this
study, as an antimicrobial agent for use in management
of shigellosis. The important sensitivity rates recorded
by these drugs are probably due to the fact that they are
l e s sa b u s e d .R e s i s t a n c et oc o t r i m o x a z o l e ,o n eo ft h e
drugs used in the treatment of shigellosis has been
reported in many studies. Belay et al. [16] demonstrated
a 55% resistance rate of Shigella strains to cotrimoxazole
while Khan-Mohammed et al. [17] recorded only 2.7%
resistance rate to this drug in Trinidad. The present
work showed a 90% resistance rate of the isolates to
cotrimoxazole which is in agreement with observations
from Yaoundé, Cameroon, Iran and Ghana [7,16] where
resistance rates of 87.8%, 92% and 100% respectively,
were reported. Unfortunately, the drug is still commonly
prescribed and used in automedication by the commu-
nity for diarrhoeal diseases and other infections due to
its availability in local and pro-pharmacies at a very low
cost. Amoxycillin and ampicillin were the next on the
chart of resistant antibiotics, with resistance rates of
80% and 70% respectively (Table 1). Looking at Table 2,
five Shigella isolates developed cross-resistance to these
two antibiotics whereas 3 (against amoxicillin) and 2
(against ampicillin) were solely resistant to each of the
amino-penicillins. They are beta-lactam penicillin anti-
biotic with bactericidal activity binding to and inactivat-
ing the penicillin-binding proteins (PBP) located on the
inner membrane of the bacterial cell wall which inter-
feres with the cross-linkage of peptidoglycan chains
necessary for bacterial cell wall strength and rigidity
[18]. The difference in resistance patterns of these 2
antibiotics may be due to the difference in administra-
tion routes. Ampicillin is administered frequently
through parenteral routes whereas amoxicillin is orally
administered. The latter is therefore more prone to
abuse related to automedication and over prescription.
Although they share in common the same resistance
mechanism, some species are able to induce resistance
to beta-lactams as a result of changes in porins in the
outer membrane. Such changes decrease or eliminate
the flow of small hydrophilic molecules like beta-lactams
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biotics of 88.5% and 78.5% respectively, were reported in
Iran [19]. Wilson et al. [20] observed a resistance rate of
39.7% by Shigella isolates to chloramphenicol compar-
able with 40% resistance rate obtained in this study.
Occurrence of Shigella species with multi drug resis-
tance to 4 and 7 antibiotics (Table 2) including mem-
bers of beta lactams (ampicilin and amoxicillin) and
cephalosporins (Ceftriaxone) is precursor of the pre-
sence in the Buea Health District of extended-spectrum
beta-lactamases (ESBLs) [21]. ESBLs are enzymes cap-
able of hydrolysing penicillins, broad-spectrum cephalos-
porins and monobactams, and are generally derived
from TEM and SHV type 3 or 4 enzymes. ESBL-produ-
cing enterobacteriaceae have been responsible for
numerous outbreaks of infection throughout the world
and pose challenging infection control issues. Antibac-
terial choice is often complicated by multi-resistance
and often leads to therapeutic failure of empirical ther-
apy; therefore knowledge of the local prevalence of
pathogens and their antimicrobial sensitivity patterns is
essential for clinicians in their routine work [15,21].
Risk factors associated with the spread of these danger-
ous strains is due to indiscriminate prescription of 3rd
generation cephalorins (ceftriaxone) and risk factors
such as living in poor hygienic conditions like in Buea
health district [22]. Penicillins and chloramphenicol are
broad-spectrum antibiotics commercially available and
affordable to the public for treatment of enteric, urinary
tract and ocular infections; thus they are often pur-
chased on the basis of self-prescription and administered
at sub-therapeutic dosages, accounting for the high rates
of resistance observed. Nalidixic acid and ofloxacin
showed resistance rate of 60% and 20% respectively
(Table 1), implying that quinolone resistance is spread-
ing in Cameroon [15]. In a previous study a resistance
rate of enterobacteriaceae of 25.7% against quinolones
has been observed. Although the quinolone resistance
mechanism described most frequently, both in Shigella
spp. and in other microorganisms, involves the presence
of mutations in the quinolone target site; nalidixic acid
resistance is related mainly to the presence of a single
amino-acid substitution at either position 83 or position
87 of GyrA, while resistance to ciprofloxacin is related
Table 1 In vitro antimicrobial susceptibility pattern of isolates
ANTIBIOTIC CLASS ANTIBIOTIC TESTED NUMBER (Percentage)
Sensitive Intermediate Resistant
Quinolone Nalidixic acid 2 (20) 2 (20) 6 (60)
Fluoroquinolones Ciprofloxacin 4(40) 6 (60) 0 (0)
Ofloxacin 7 (70) 1 (10) 2 (20)
Macrolide Azithromycin 8 (80) 1 (10) 1 (10)
Cephalosporin Ceftriaxone 7(70) 1(10) 2(20)
Aminoglycoside Gentamicin 4 (40) 2 (20) 4 (40)
Sulfonamide and trimethoprime Cotrimoxazole 1 (10) 0 (0) 9 (90)
Penicillins Amoxycillin 2 (20) 0 (0) 8 (80)
Ampicillin 2 (20) 1 (10) 7 (70)
Chloramphenicols Chloramphenicol 4 (40) 2 (20) 4(40)
c
2 = 3.93, df = 4, p = 0.42
Table 2 Drug resistance patterns of Shigella isolates
Resistance patterns Antibiotics Number and percentage of resistant isolates n = 10)
2 antibiotics AMX, A 1 (10)
3 antibiotics AMX, NA, SXT 1 (10)
4 antibiotics A, C, NA, SXT 1 (10)
A, CN, CRO, SXT 1 (10)
AMX, A, CN, SXT 2 (20)
5 antibiotics AMX, A, C, NA, SXT 1 (10)
AMX, A, NA, OFX, SXT 1 (10)
AMX, A, C, NA, SXT 1 (10)
7 antibiotics AMX, C, CN, CRO, OFX, NA, SXT 1 (10)
AMX: Amoxycillin; A: Ampicillin; AZM: Azithromycin; C: Chloramphenicol; CIP: Ciprofloxacin; CN: Gentamicin; CRO: Ceftriaxone; OFX: Ofloxacin; NA: Nalidixic acid;
SXT: Cotrimoxazole
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GyrA or ParC [23]; this difference may also be due to
the presence of efflux pumps in Shigella spp. that are
able to confer quinolone resistance in the absence of
GyrA substitution. The widespread use of these agents
might account for the high percentage of quinolone-
resistant isolates in the study area[24] as compared with
findings from Mache [25] who reported a resistance rate
of 6.5%; and Andrea et al. [17] who recorded 40%. This
shows a constant increase in resistance rates as the
years go by. The same trend applies to gentamicin;
Gizachew et al. [8] in a comparative study of the resis-
tance rate of Shigella species to commonly used antibio-
tics in different years in Ethiopia observed a fourfold
increase in resistance to gentamicin; from 2% as stated
by Assefa et al. [26] to 7.9% by Gizachew et al. [8]. They
attributed this change to an increase in the use of the
drug over the past 5 years. The resistance rate obtained
w i t hg e n t a m i c i ni nt h ep r e s e n ts t u d y( 4 0 % )( T a b l e1 )
was higher than those reported in the above studies.
Multiple-drug resistance to as many as seven antibiotics
was observed here (Table 2) and this is similar to Belay
et al. [16] and Wilson et al. [20]’s findings where resis-
tance to six and seven antibiotics were found, among
which ampicillin, cotrimoxazole and gentamicin, showed
the highest occurring resistance pattern. Murray et al.
[27] contended that resistance is encountered more with
those antibiotics misused or used frequently for thera-
peutic and/or prophylactic purposes. Cotrimoxazole,
ampicillin and amoxycilin are easily obtained outside of
recognized treatment centers and taken without medical
supervision at sublethal dosages and during an insuffi-
cient length of time. Buea, being a cosmopolitan town
and owing to the fact that a significant portion of the
population is made up of university students; there is a
frequent movement in and out of the town. This mobile
population provides opportunities for the rapid spread
of multi-resistant organisms in regions where unrest-
ricted antibiotic use is common, scarcity of potable
water combined with many factors favouring live in
poor hygienic conditions. Unless the unrestricted use of
these antibiotics is stopped in this area, the time that
these antibiotics become ineffective in the treatment of
bacillary dysentery and other infectious agents is not far.
This study which highlights the epidemiologic pattern
of shigellosis in the Buea Health District however has a
limitation including the inability to determine the spe-
cies of Shigella or to serotype them. Information that
could have given an idea of the severity of the species
involved. However according to WHO [13], reporting
any isolate of Shigella species is a major step in disease
surveillance and helps in taking actions that lessen the
risk of serious complications, spreading and death in the
population.
Conclusions
This work has revealed that the prevalence rate of shi-
gellosis in the Buea Health District in Cameroon stands
at 4.5%. The majority of Shigella isolates are from the
paediatric population (children < 15 years) with an
infection rate of 7.89%. This condition is linked to the
poor hygienic conditions prevailing in the area. The
antibiotic susceptibility testing has revealed that these
Shigella spp are multiresistant to currently used antibio-
tics including extended-spectrum beta-lactamses
(ESBLs) as well as increasing evidence of resistance to
quinolones. Azithromycin was found to be the drug of
choice for shigellosis in this setting.
Methods
A total of 223 individuals comprising of 90 males and
133 females, aged 1 month to 72 years old were
recruited in the study. The participants were patients
referred to the laboratory for stool analysis from the
in-patient and out-patient departments of the Regional
Hospital Annex, Buea and the Kahwa Sumbele Medical
Centre Bomaka, all within the Buea Health District.
Their informed consent was souk and obtained and an
ethical clearance and authorization to collect specimen
and data for research was obtained from the South
West Regional Delegation of Public Health Ref No.
R11/MPH/SWR/RDPH/FP/5489/97 of the 06/04/2010.
An estimate of the required number of participants
was obtained using a formula for estimating sample
size for proportions. The prevalence used in this for-
mula was derived from a previous work [6]. Isolation,
morphological and biochemical identification of Shi-
gella spp were done according to standard methods
[28]. The confirmed isolates were subjected to antimi-
crobial susceptibility tests by disc diffusion method
[29-31].
(For details of the methods used see Additional file 1).
Additional material
Additional file 1: Methods.
Acknowledgements
The authors acknowledge with thanks, the University of Buea Departmental
Research Grant (Department of Medical Laboratory Sciences) for sponsoring
this work.
Author details
1Department of Medical Laboratory Sciences, Faculty of Health Sciences,
University of Buea, P.O.Box 63, Buea, Cameroon.
2Medicine Programme,
Department of Biomedical Sciences, Faculty of Health Sciences Laboratory,
University of Buea, P.O.Box 63, Buea, Cameroon.
3Department of Public
Health and Hygiene, Faculty of Health Sciences, University of Buea, P.O.Box
63, Buea, Cameroon.
4Department of Clinical Sciences, Faculty of Health
Sciences, University of Buea, P.O.Box 63, Buea, Cameroon.
Njunda et al. BMC Research Notes 2012, 5:54
http://www.biomedcentral.com/1756-0500/5/54
Page 4 of 5Authors’ contributions
ALN as principal investigator designed and implemented the project and
initiated the writing of the manuscript. JCNA assisted in designing the
project and revised the manuscript. HLFK assisted in the in vitro
antimicrobial testing and in revising the paper. DSN assisted in the
identification of microbial strains, the statistical analysis of data and in
revising the paper. MPA provided technical assistance during antimicrobial
testing. EPW assisted during the consultation in making sure that patients
enrolled in the study presented with signs and symptoms of diarrhoea, he
read and approved the final version of the manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 27 September 2011 Accepted: 21 January 2012
Published: 21 January 2012
References
1. Niyogi SK: Shigellosis. J Microbiol 2005, 43:33-43.
2. Watanabe T: Infective heredity of multiple drug resistance in bacteria.
Bacteriology Review 1963, 27:87-115.
3. Sack BR, Rahman M, Yunus M, Khan HE: Antimicrobial resistance in
organisms causing diarrheal disease. Clinical Infectious Disease 2007,
24:102-105.
4. Guyot A: Antibiotic resistance of Shigella in Monrovia, Liberia. Tropical
Diseases 1969, 26:70-71.
5. Brito A, Nij B: Antibiotic resistance pattern and plasmid profiles for
Shigella species isolated in Cordoba, Argentina. Antimicrob Agents and
Chemotherapy 1994, 34:253-259.
6. Nguendo YB: Pathogenic microorganisms associated with childhood
diarrhea in low and middle income countries: case study of Yaounde-
Cameroon. Int J Environ Res Public Health 2008, 5:213-229.
7. Fotsing K: Etude sur la prévalence des différents agents pathogènes, bactériens
chez les enfants de moins de 5 ans à Yaoundé Colloque scientifique des
Instituts Pasteur; 2001, 239-244.
8. Gizachew Y, Challa N, Afework K: A five year antimicrobial resistance
pattern observed in Shigella species isolated from stool samples in
Gondar University Hospital, Northwest Ethiopia. Ethiopian J Health
Development 2006, 20:194-198.
9. Patrick R, Muray S, Rosenthal K, Michael A: Medical miocrobiology. 5 edition.
USA. Elsevier Mosby; 2002, 323-333.
10. Taylor D, Echeverria P, Pal T: The role of Shigella spp., enteroinvasive
Escherichia coli and other enteropathogens as causes of childhood
dysentery in Thailand. J Infectious Diseases 2006, 153:1132-1138.
11. Pablo VE, Torres A, Freire JM, Hernandez V, Gil A: Factors associated to
infant mortality in Sub-Saharan Africa. J Public Health In Africa 2011, 2:e27.
12. Levine MM: Shigellosis. Strickland GT, Hunter’s Tropical Medicine. 7 edition.
Philadelphia WB Saunders Co; 2000, 340-344.
13. World Health Organization: Guidelines for the control of shigellosis, including
epidemics due to Shigella dysenteriae 1 WHO Document Production Services,
Geneva, Switzerland; 2005, 1-64.
14. Neu H: The crisis in antibiotics resistance. J Science 1992, 257:1064.
15. Toukam M, Lyonga EE, Assoumou MCO, Fokunang CN, Atashili J, Kechia AF,
Gonsu HK, Mesembe M, Eyoh A, Ikomey G, Akongnwi E, Ndumbe P:
Quinolone and fluoroquinolone resistance in Enterobacteriaceae isolated
from hospitalised and community patients in Cameroon. J Med Med Sci
2010, 1:490-494.
16. Belay R, Solomon W, Shiferaw T, Nina A: Antimicrobial susceptibility
pattern of Shigella isolates in Awasa, Ethiopian. Ethiopian J Health and
Dev 2000, 14:149-154.
17. Khan-Mohammed Z, Adesiyun AA, Swanston WH, Chadee DD: Frequency
characteristics of selected enteropathogens in fecal and rectal
specimens from childhood dirrhoea in Trinidad, 1998-2000. Rev Panam
Salud Publica 2005, 17:170-177.
18. Tenover FC: Mechanisms of antimicrobial resistance in bacteria. Amer J
Inf Control 2006, 34:S3-S10.
19. Rahbar M, Deldari M, Hajia M: Changing prevalence and antibiotic
susceptibility patterns of different Shigella species in Teheran, Iran. The
Internet J Microbiol 2007, 3:2.
20. Wilson G, Joshy ME, Chiranjoy M, Shivananda PG: Isolation and
antimicrobial susceptibility of shigella from patients with acute
gastroenteritis in western Nepal. Indian J Med 2006, 1:145-150.
21. Shah A, Hasan F, Ahmed S, Hameed A: Extended-Spectrum β-Lactamases
(ESBLs): Characterization, Epidemiology and Detection. Critical Reviews in
Microbiology 2004, 30:25-32.
22. Admoni O, Yagupsky P, Avivit G, Schifron G, Horowitz I: Epidemiological,
Clinical and Microbiological Features of Shigellosis among Hospitalized
Children in Northern Israel. Scand J Infect Dis 1995, 27:139-144.
23. Ruiz J: Mechanisms of resistance to quinolones: target alterations,
decreased accumulation and DNA gyrase protection. J Antimicrob
Chemother 2003, 51:1109-1117.
24. Mensa L, Marco F, Vila J, Gasco J, Ruiz NJ: Quinolone resistance among
Shigella spp. isolated from travellers returning from India. Clin Microbiol
Infect 2008, 14:279-281.
25. Mache A: Antibiotic resistance and serogroups of Shigella among
pediatric outpatients in Southwest Ethiopia. East African Medical J 2001,
78:6.
26. Assefa A, Gedlu E, Ashmelash T: Antibiotic resistance of prevalent
Salmonella and Shigella strains in Northwest Ethiopia. East Afr Med J
2006, 74:36-41.
27. Murray BE: Resistance of Salmonella, Shigella and other selected enteric
pathogens to antimicrobial agents. Infect Dis Rev 2002, 8:172-181.
28. Bopp CA, Brenner FW, Wells J, Strockbine NA: Escherichia, Shigella and
Salmonella. In Manual of Clinical Microbiology.. 7 edition. Edited by: Murray
PR, Pfaller MA, Tenover FC, Baron EJ, Yolken RH. Washington, DC: ASM
Press; 2000:459-474.
29. Cheesbrough M: In Antibiotic sensitivity testing, Enterobactereaceae. In
Medical Laboratory Manual for tropical countries. Volume 2. Cambridge
University Press; 2000:132-138, Microbiology EIBS pub. Low price Edition.
30. Bauer AW, Kirby WW, Sheris JC, Tuek M: Antibiotic susceptibility testing by
standardized single disc method. American J Clinical Pathology 1966,
36:493-496.
31. National Committee for Clinical Laboratory Standards: Performance standard
for antimicrobial disk susceptibility tests: approved standards. 6 edition.
Wayne; 2003, NCCLS document M2-A6.
doi:10.1186/1756-0500-5-54
Cite this article as: Njunda et al.: Epidemiological, clinical features and
susceptibility pattern of shigellosis in the Buea Health District,
Cameroon. BMC Research Notes 2012 5:54.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Njunda et al. BMC Research Notes 2012, 5:54
http://www.biomedcentral.com/1756-0500/5/54
Page 5 of 5